These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 8410147)
1. Relationship of perfusion to edema in the 9L gliosarcoma. Steen RG; Kromhout-Schiro S; Graham MM J Neurooncol; 1993 Apr; 16(1):81-7. PubMed ID: 8410147 [TBL] [Abstract][Full Text] [Related]
2. 31P magnetic resonance spectroscopy is sensitive to tumor hypoxia: perfusion and oxygenation of rat 9L gliosarcoma after treatment with BCNU. Steen RG; Graham MM NMR Biomed; 1991 Jun; 4(3):117-24. PubMed ID: 1911098 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor. Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919 [TBL] [Abstract][Full Text] [Related]
4. Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. DiMeco F; Rhines LD; Hanes J; Tyler BM; Brat D; Torchiana E; Guarnieri M; Colombo MP; Pardoll DM; Finocchiaro G; Brem H; Olivi A J Neurosurg; 2000 Mar; 92(3):419-27. PubMed ID: 10701528 [TBL] [Abstract][Full Text] [Related]
5. The effect of dexamethasone on the uptake of p-boronophenylalanine in the rat brain and intracranial 9L gliosarcoma. Morris GM; Micca PL; Coderre JA Appl Radiat Isot; 2004 Nov; 61(5):917-21. PubMed ID: 15308168 [TBL] [Abstract][Full Text] [Related]
6. Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. Darpolor MM; Molthen RC; Schmainda KM PLoS One; 2011 Jan; 6(1):e16621. PubMed ID: 21305001 [TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159 [TBL] [Abstract][Full Text] [Related]
8. TmDOTP(5-) as a (23)Na shift reagent for the subcutaneously implanted 9L gliosarcoma in rats. Winter PM; Bansal N Magn Reson Med; 2001 Mar; 45(3):436-42. PubMed ID: 11241701 [TBL] [Abstract][Full Text] [Related]
9. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy. Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448 [TBL] [Abstract][Full Text] [Related]
10. A 9L gliosarcoma transplantation model for studying adoptive immunotherapy into the brains of conscious rats. Fleshner M; Watkins LR; Redd JM; Kruse CA; Bellgrau D Cell Transplant; 1992; 1(4):307-12. PubMed ID: 1344303 [TBL] [Abstract][Full Text] [Related]
11. Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors. Iwadate Y; Yamaura A; Sato Y; Sakiyama S; Tagawa M Cancer Res; 2001 Dec; 61(24):8769-74. PubMed ID: 11751397 [TBL] [Abstract][Full Text] [Related]
12. Deuterium NMR tissue perfusion measurements using the tracer uptake approach: II. Comparison with microspheres in tumors. Simpson NE; Evelhoch JL Magn Reson Med; 1999 Aug; 42(2):240-7. PubMed ID: 10440948 [TBL] [Abstract][Full Text] [Related]
13. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316 [TBL] [Abstract][Full Text] [Related]
14. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma. Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922 [TBL] [Abstract][Full Text] [Related]
15. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496 [TBL] [Abstract][Full Text] [Related]
16. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810 [TBL] [Abstract][Full Text] [Related]
17. The efficacy and distribution of suramin in the treatment of the 9L gliosarcoma. Olson JJ; Polk DM; Reisner A Neurosurgery; 1994 Feb; 34(2):297-308; discussion 308. PubMed ID: 8177391 [TBL] [Abstract][Full Text] [Related]